|
Volumn 19, Issue 6, 2000, Pages 17-24
|
Apnea of prematurity: diagnosis, implications for care, and pharmacologic management.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
METHYLXANTHINE;
OXYGEN;
XANTHINE DERIVATIVE;
APNEA;
ARTIFICIAL VENTILATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
MALE;
MASK;
MONITORING;
MULTIMODALITY CANCER THERAPY;
NEWBORN;
NEWBORN INTENSIVE CARE;
NURSING;
PREMATURITY;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
APNEA;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
INFANT, PREMATURE, DISEASES;
INTENSIVE CARE UNITS, NEONATAL;
MALE;
MASKS;
MONITORING, PHYSIOLOGIC;
OXYGEN;
PROGNOSIS;
RESPIRATION, ARTIFICIAL;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
XANTHINES;
|
EID: 0034286030
PISSN: 07300832
EISSN: None
Source Type: Journal
DOI: 10.1891/0730-0832.19.6.17 Document Type: Review |
Times cited : (17)
|
References (65)
|